MENU
Showcases Stock ranks Forex

Kenvue Inc (KVUE)
20.475  0.025 (0.12%) 05-09 15:47
Open: 20.51 Pre. Close: 20.45
High: 20.61 Low: 20.365
Volume: 10,078,911 Market Cap: 39,201(M)
Stock Technical Analysis
Overall:     
Target: Six months: 24.15
One year: 28.21
Support: Support1: 19.42
Support2: 18.64
Resistance: Resistance1: 20.68
Resistance2: 24.15
Pivot: 19.38
Moving Averages: MA(5): 19.86
MA(20): 19.35
MA(100): 20.21
MA(250): 21.65
MACD: MACD(12,26): 0.01
Signal(12,26,9): -0.18
%K %D: %K(14,3): 90.02
%D(3): 74.87
RSI: RSI(14): 64.28
52-Week: High: 27.795
Low: 17.82
Change(%): -21.2
Average Vol(K): 3-Month: 16822
10-Days: 19445
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 20.705 - 20.782 20.782 - 20.844
Low: 19.785 - 19.88 19.88 - 19.957
Close: 20.305 - 20.454 20.454 - 20.574
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

[ KVUE ] has closed Bollinger Bands are 23.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Company profile
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Stock chart
Stock News
Thu, 09 May 2024
M&T Bank Corp Raises Stake in Kenvue Inc. (NYSE:KVUE) - Defense World

Thu, 09 May 2024
Q2 2024 Earnings Estimate for Kenvue Inc. (NYSE:KVUE) Issued By William Blair - Defense World

Thu, 09 May 2024
International Assets Investment Management LLC Acquires 186271 Shares of Kenvue Inc. (NYSE:KVUE) - Defense World

Wed, 08 May 2024
Charles Schwab Investment Management Inc. Increases Holdings in Kenvue Inc. (NYSE:KVUE) - MarketBeat

Tue, 07 May 2024
Kenvue (NYSE:KVUE) Trading 5.2% Higher - MarketBeat

Tue, 07 May 2024
Kenvue Layoffs 2024: What to Know About the Latest KVUE Job Cuts - InvestorPlace

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Consumer Defensive
Industry:  Household & Personal Products
Shares Out. (M) 1910.00
Shares Float (M) 1730.00
% Held by Insiders 0.02
% Held by Institutions 99.80
Shares Short (K) 36030
Shares Short Prior Month (K) 27450
Stock Financials
EPS 0.900
Book Value (p.s.) 5.850
Profit Margin 10.77
Operating Margin 16.12
Return on Assets (ttm) 6.7
Return on Equity (ttm) 10.7
Qtrly Rev. Growth -2.7
Gross Profit (p.s.)
Sales Per Share 8.084
EBITDA (p.s.) 1.869
Qtrly Earnings Growth -18.70
Operating Cash Flow (M) 3170.00
Levered Free Cash Flow (M) 2800.00
Stock Valuation
PE Ratio 22.77
PEG Ratio 13.86
Price to Book value 3.50
Price to Sales 2.53
Price to Cash Flow 12.35
Stock Dividends
Dividend
Dividend Yield
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android